Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Apr-24 4:23 PM View:  | Schallenberger Mark A. Chief Operations Officer | Xtant Medical Holdings, Inc. (XTNT) | 03-Apr-24 | Grant | 177,551 | -- | -- | 87% 205.14K to 382.69K | |
| 05-Apr-24 4:30 PM View: | Browne Sean E President and CEO Director | Xtant Medical Holdings, Inc. (XTNT) | 03-Apr-24 | Grant | 731,632 | -- | -- | 46% 1.58M to 2.31M | |
| 05-Apr-24 4:17 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 03-Apr-24 | Grant | 177,551 | -- | -- | 36% 486.87K to 664.42K | |
| 05-Apr-24 4:37 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 03-Apr-24 | Grant | 184,209 | -- | -- | 23% 815.86K to 1.0M | |
| 18-Jan-24 4:11 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 16-Jan-24 | Payment of Exercise | 7,986 | $1.09 | $8,704.74 | (2%) 494.86K to 486.87K | |
| 17-Nov-23 4:42 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 17-Nov-23 | Purchase | 41,670 | $1.20 | $49,837.30 | 5% 774.19K to 815.86K | |
| 17-Oct-23 4:43 PM View: | Browne Sean E President and CEO Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Oct-23 | Payment of Exercise | 111,721 | $1.08 | $120,659.00 | (7%) 1.68M to 1.57M | |
| 17-Aug-23 4:38 PM View: | Vizirgianakis Stavros G. Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 217,770 | -- | -- | 4% 6.0M to 6.21M | |
| 17-Aug-23 4:46 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Payment of Exercise | 49,880 | $1.18 | $58,858.40 | (6%) 824.07K to 774.19K | |
| 17-Aug-23 4:10 PM View: | Bakewell John K Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 145,180 | -- | -- | 32% 448.55K to 593.73K | |
| 17-Aug-23 4:32 PM View: | Mitchell-Keller Lori D Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 145,180 | -- | -- | 317% 45.78K to 190.96K | |
| 17-Aug-23 5:01 PM View: | Browne Sean E President and CEO Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 174,216 | -- | -- | 12% 1.51M to 1.68M | |
| 17-Aug-23 5:11 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 116,144 | -- | -- | 29% 403.96K to 520.1K | |
| 17-Aug-23 5:20 PM View: | Schallenberger Mark A. Chief Operations Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 116,144 | -- | -- | 130% 89.0K to 205.14K | |
| 17-Aug-23 4:25 PM View: | McNamara Robert Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 145,180 | -- | -- | 32% 446.81K to 591.99K | |
| 17-Aug-23 4:46 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 120,499 | -- | -- | 17% 703.57K to 824.07K | |
| 17-Aug-23 4:18 PM View: | Beeson Jonn R. Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Grant | 145,180 | -- | -- | 14% 1.07M to 1.21M | |
| 17-Aug-23 5:11 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-23 | Payment of Exercise | 25,246 | $1.18 | $29,790.30 | (5%) 520.1K to 494.86K | |
| 15-Jun-23 4:14 PM View: | Mitchell-Keller Lori D Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Jun-23 | Grant | 45,782 | -- | -- | 100% 0 to 45.78K | |
| 16-May-23 5:02 PM View: | Beeson Jonn R. Director | Xtant Medical Holdings, Inc. (XTNT) | 15-May-23 | Grant | 52,049 | -- | -- | 5% 1.02M to 1.07M | |
| 17-Feb-23 4:42 PM View: | Schallenberger Mark A. Chief Operations Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Feb-23 | Grant | 89,000 | -- | -- | 100% 0 to 89.0K | |
| 19-Jan-23 4:23 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 18-Jan-23 | Market Sale (Planned) | 8,673 | $0.61 | $5,282.72 | (2%) 412.63K to 403.96K | 3% |
| 17-Nov-22 4:19 PM View: | Vizirgianakis Stavros G. Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Nov-22 | Grant | 144,639 | -- | -- | 2% 5.85M to 6.0M | |
| 20-Oct-22 4:19 PM View: | Browne Sean E President and CEO Director | Xtant Medical Holdings, Inc. (XTNT) | 19-Oct-22 | Sale (Planned) | 51,100 | $0.62 | $31,820.00 | (3%) 1.56M to 1.51M | |
| 20-Oct-22 4:19 PM View: | Browne Sean E President and CEO Director | Xtant Medical Holdings, Inc. (XTNT) | 18-Oct-22 | Private Sale (Planned) | 80,000 | $0.68 | $54,008.00 | (5%) 1.64M to 1.56M | |
| 11-Oct-22 4:48 PM View: | Vizirgianakis Stavros G. Director | Xtant Medical Holdings, Inc. (XTNT) | 07-Oct-22 | Private Purchase | 2,264,860 | $0.48 | $1,087,130.00 | 63% 3.59M to 5.85M | |
| 26-Aug-22 4:39 PM View: | Vizirgianakis Stavros G. Director | Xtant Medical Holdings, Inc. (XTNT) | 25-Aug-22 | Grant | 70,776 | -- | -- | 2% 3.52M to 3.59M | |
| 17-Aug-22 5:28 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 17-Aug-22 | Sale (Planned) | 4,300 | $0.48 | $2,049.38 | (< 1%) 707.87K to 703.57K | |
| 17-Aug-22 5:10 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 17-Aug-22 | Sale (Planned) | 1,270 | $0.48 | $605.03 | (< 1%) 413.9K to 412.63K | |
| 17-Aug-22 5:28 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 16-Aug-22 | Sale (Planned) | 18,700 | $0.49 | $9,172.35 | (3%) 726.57K to 707.87K | |
| 17-Aug-22 5:10 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 16-Aug-22 | Sale (Planned) | 5,100 | $0.48 | $2,460.24 | (1%) 419.0K to 413.9K | |
| 17-Aug-22 4:37 PM View: | Bakewell John K Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-22 | Grant | 215,415 | -- | -- | 92% 233.13K to 448.55K | |
| 17-Aug-22 5:10 PM View: | Neils Scott C Chief Financial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-22 | Grant | 251,895 | -- | -- | 151% 167.11K to 419.0K | |
| 17-Aug-22 4:44 PM View: | McNamara Robert Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-22 | Grant | 215,415 | -- | -- | 93% 231.39K to 446.81K | |
| 17-Aug-22 4:50 PM View: | Peters Jeffrey J Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-22 | Grant | 215,415 | -- | -- | 92% 233.13K to 448.55K | |
| 17-Aug-22 5:28 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-22 | Grant | 410,079 | -- | -- | 130% 316.49K to 726.57K | |
| 17-Aug-22 4:12 PM View: | Eggenberg Michael Director 10% Owner | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-22 | Grant | 215,415 | -- | -- | < 1% 73.11M to 73.33M | |
| 17-Aug-22 4:04 PM View: | Rizzo Matthew Director 10% Owner | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-22 | Grant | 215,415 | -- | -- | < 1% 73.11M to 73.33M | |
| 18-Jan-22 4:12 PM View: | Neils Scott C Interim Chief Financial Office | Xtant Medical Holdings, Inc. (XTNT) | 15-Jan-22 | Grant | 88,983 | -- | -- | 114% 78.13K to 167.11K | |
| 18-Oct-21 4:21 PM View: | Browne Sean E President and CEO Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Oct-21 | Payment of Exercise | 160,219 | $1.11 | $177,843.00 | (9%) 1.8M to 1.64M | 0% |
| 17-Aug-21 5:04 PM View: | McNamara Robert Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-21 | Grant | 85,337 | -- | -- | 58% 146.06K to 231.39K | |
| 17-Aug-21 4:44 PM View: | Rizzo Matthew Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-21 | Grant | 85,337 | -- | -- | < 1% 72.91M to 72.99M | |
| 17-Aug-21 5:11 PM View: | Peters Jeffrey J Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-21 | Grant | 85,337 | -- | -- | 58% 147.79K to 233.13K | |
| 17-Aug-21 5:32 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-21 | Payment of Exercise | 7,169 | $1.20 | $8,602.80 | (2%) 323.66K to 316.49K | |
| 17-Aug-21 5:32 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 15-Aug-21 | Grant | 162,109 | -- | -- | 100% 161.55K to 323.66K | |
| 13-Jul-21 5:03 PM View: | Brandt Kevin D Chief Commercial Officer | Xtant Medical Holdings, Inc. (XTNT) | 09-Jul-21 | Payment of Exercise | 8,800 | $1.74 | $15,312.00 | (5%) 170.35K to 161.55K | (15%) |
| 19-Nov-20 5:33 PM View: | Eggenberg Michael Director 10% Owner | Xtant Medical Holdings, Inc. (XTNT) | 17-Nov-20 | Exercise (in-the money or at-the-money) Duplicate | 4,800,000 | $0.01 | $48,000.00 | 7% 68.07M to 72.87M | |
| 19-Nov-20 5:11 PM View: | Rizzo Matthew Director 10% Owner | Xtant Medical Holdings, Inc. (XTNT) | 17-Nov-20 | Exercise (in-the money or at-the-money) | 4,800,000 | $0.01 | $48,000.00 | 7% 68.07M to 72.87M | |
| 19-Nov-20 6:02 PM View: | Orbimed Advisors LLC Director 10% Owner | Xtant Medical Holdings, Inc. (XTNT) | 17-Nov-20 | Exercise (in-the money or at-the-money) Duplicate | 4,800,000 | $0.01 | $48,000.00 | 7% 68.07M to 72.87M | |
| 16-Nov-20 4:16 PM View: | Browne Sean E President and Chief Executive Director | Xtant Medical Holdings, Inc. (XTNT) | 15-Nov-20 | Grant | 1,468,860 | -- | -- | 446% 329.04K to 1.8M |
